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Coronary artery disease varies
seasonably in subtropics
Editor—Seto et al’s findings of seasonal
variation in mortality from coronary artery
disease in Hawaii1 are similar to our own
findings in Hong Kong, a subtropical city.
Hong Kong has 6.2 million people
residing and working in an urban and
suburban area of about 1070 km2. In
summer and autumn (May›October) the
temperature is warm (mean 27°C; range
22›30°C); in winter and spring (November›
April) it is an average of 8°C cooler (19°C;
7›27°C).
As a single disease entity, coronary
artery disease (ICD›9 410›414) emerged as
the biggest killer in Hong Kong (3181
deaths in 1992). The sex difference in
mortality is smaller than in other parts of
the world; for the 40›69 age group the
male to female ratio was 2.4 compared with
2.8 for the United States and 3.3 for
England and Wales, and prevalence was
greater in higher than in lower socioeco›
nomic groups. The age standardised mor›
tality (based on Segi’s world populations2)
from 1972 to 1992 stayed close to
60/100 000 for men and slightly above
30/100 000 for women—lower than in all
countries except Japan,3 and less than half
the rate in Hawaii.
The crude death rates for coronary
artery disease, with three month moving
averages (figure), show a strong seasonal
variation and, compared with Hawaii, a
stronger correlation with temperature
(r = − 0.60 v − 0.55), total hours of bright
sunshine (r = − 0.30 v − 0.27) and deaths
from respiratory infection (r = 0.53 v 0.41),
P < 0.001 for all. The difference between the
peak month (January) and trough month
(September) was greater than that in Hawaii
(37% v 22%) and the figures quoted for
Scotland and New Zealand.
Seto et al interpret their data as showing
that small changes in weather may affect
mortality. In Hawaii, although monthly vari›
ation in temperature was small, the changes
in hours of sunlight were marked and would
be highly correlated with temperature.
The magnitude of seasonal variation in
both coronary artery disease and respira›
tory deaths in the subtropical city of Hong
Kong is stronger than that in the Hawaiian
tropical climate and comparable to or
greater than that in other temperate zones.
Studies in seasonal variation of disease may
shed light on the cause of terminal events in
coronary artery disease.
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Acute urinary retention in men
Management is more complex issue than
was described
Editor—Emberton and Anson’s review of
acute urinary retention was timely and
informative.1 In part of it they focused on the
use of finasteride to reduce the risk of the
disease.2 We disagree with them that the
continuous administration of finasteride for
four years is probably warranted in men
with large prostates, moderate to severe
symptoms, and poor urinary flow rates.
Firstly, the cost implications are enor›
mous. To prevent one event (acute urinary
retention or prostatectomy) 15 patients
would have to be treated for four years at a
cost of £19 475.3 Secondly, the reduction in
mean symptom scores with long term finas›
teride treatment is small (mean reduction
3.3 points) and not comparable with the
results obtained after prostatectomy (mean
reduction 19.4 points).4 Furthermore, what
should happen after four years of treatment
has not been established. Should finasteride
treatment be stopped, with the probability of
prostatic regrowth, or should patients take it
for life? The answers are not known. We
therefore conclude that long term finas›
teride is not efficient or cost effective in pre›
venting acute urinary retention and that
prostatectomy should remain first line treat›
ment in such patients.
The review also describes patients with
drained bladder volumes of more than 1
litre and low detrusor pressures who have a
worse outcome (failure of catheter removal
or failure of prostatectomy). Most urologists
would describe this group as having chronic
urinary retention, although there are no
agreed criteria defining this condition.
Uniform standards are urgently needed to
evaluate data and therefore compare differ›
ent treatments.
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Authors’ reply
Editor—The principal concern of Elkabir
et al relates to the cost of preventing one
episode of acute urinary retention by use of
finasteride. Unfortunately, their calculation
was incorrect. Their mistake was to apply the
overall treatment effect (finasteride v pla›
cebo) to their analysis rather than calculate
the numbers needed to treat for the group
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Seasonal variation (broken line shows three month moving average) in monthly death rates from coronary
artery disease, with average temperature, hours of sunlight, and deaths from respiratory infection
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